Grasp on November 4th | Bocom Intl released a report stating that New China Life Insurance achieved a year-on-year growth of 116.7% in net income attributable to mothers in the first three quarters, slightly higher than the upper limit of the range previously announced by the company (95% to 115%). Looking at the quarterly performance, the profit for the third quarter alone was 9.6 billion yuan, a significant increase compared to the net loss in the same period last year, mainly benefiting from the rebound in stock investment income. The company reported a net loss of 0.83 billion yuan in the fourth quarter of last year, expecting further improvement in full-year performance in 2024 compared to the first three quarters. The bank believes that New China Life Insurance's premium income for the first three quarters increased by 1.9% year-on-year, with growth mainly coming from renewal premiums, but offset by the year-on-year decline in single premiums received from bancassurance. The new business value increased by 79.2% year-on-year, with growth accelerating further from the first half of the year, leading the industry in growth rate. Investment assets increased by 19% compared to the beginning of the year. The annual total investment yield is 6.8%, increasing by 4.5 percentage points year-on-year, higher than the industry average. The bank raised its profit forecast for New China Life Insurance, expecting a two-fold increase in profit in 2024 from a low base, raising the target price from HK$20.5 to HK$30.5, maintaining a "buy" rating.
大行评级|交银国际:上调新华保险目标价至30.5港元 新业务价值增速领先同业
Major bank rating | Bocom Intl: Raised New China Life Insurance target price to 30.5 Hong Kong dollars, leading growth in new business value.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.